Author:
Bayart Cheryl B.,DeNiro Katherine L.,Brichta Lars,Craiglow Brittany G.,Sidbury Robert
Reference5 articles.
1. Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis;Craiglow;J Invest Dermatol,2014
2. Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata;Kennedy Crispin;JCI Insight,2016
3. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata;Mackay-Wiggan;JCI Insight,2016
4. Kavanaugh AF, Geier J, Bingham C, et al. Real world results from a post-approval safety surveillance of tofacitinib (Xeljanz): over 3 year results from an ongoing US-based rheumatoid arthritis registry. Presented at: American College of Rheumatology Annual Meeting; Nov. 11-16, 2016; Washington, DC.
5. Topical ruxolitinib for the treatment of alopecia universalis;Craiglow;JAMA Dermatol,2016
Cited by
83 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献